[HTML] frontiersin.org

[HTML][HTML] Can lymphocytes serve as a predictor of response to preoperative chemoradiation therapy for locally advanced rectal cancer?

M Lutsyk, T Taha, S Billan - Frontiers in Oncology, 2023 - frontiersin.org
Introduction The aim of this study is to identify factors that may predict the response of locally
advanced rectal cancer tumors (LARC) to neoadjuvant chemoradiotherapy (CRT) and to …
相关文章
[HTML] nih.gov

[HTML][HTML] Can lymphocytes serve as a predictor of response to preoperative chemoradiation therapy for locally advanced rectal cancer?

M Lutsyk, T Taha, S Billan - Frontiers in Oncology, 2023 - ncbi.nlm.nih.gov
Methods This retrospective study included neoadjuvant CRT-treated, LARC-diagnosed
patients at the Rambam Health Care Campus in Haifa, Israel. CHAID analysis, t-test, χ 2 test …

Can lymphocytes serve as a predictor of response to preoperative chemoradiation therapy for locally advanced rectal cancer?

M Lutsyk, T Taha, S Billan - Frontiers in Oncology, 2023 - europepmc.org
Methods This retrospective study included neoadjuvant CRT-treated, LARC-diagnosed
patients at the Rambam Health Care Campus in Haifa, Israel. CHAID analysis, t-test, χ2 test …

Can lymphocytes serve as a predictor of response to preoperative chemoradiation therapy for locally advanced rectal cancer?

M Lutsyk, T Taha, S Billan - Frontiers in oncology, 2023 - pubmed.ncbi.nlm.nih.gov
Introduction The aim of this study is to identify factors that may predict the response of locally
advanced rectal cancer tumors (LARC) to neoadjuvant chemoradiotherapy (CRT) and to …

Can lymphocytes serve as a predictor of response to preoperative chemoradiation therapy for locally advanced rectal cancer?

M Lutsyk, T Taha, S Billan - Frontiers in Oncology, 2023 - europepmc.org
Methods This retrospective study included neoadjuvant CRT-treated, LARC-diagnosed
patients at the Rambam Health Care Campus in Haifa, Israel. CHAID analysis, t-test, χ 2 test …